1Pluske, JR, Hampson, DJ & Williams, IH (1997) Factors influencing the structure and function of the small intestine in the weaned pig: a review. Livest Prod Sci 51, 215–236.
2Hopwood, DE, Pluske, JR & Hampson, DJ (2005) . In Biology of Nutrition in Growing Animals, pp. 365–385 [Mosenthin, R, Zentek, J and Zebrowska, T, editors]. Amsterdam: Elsevier Ltd.
3Radostits, OM, Leslie, KE & Fetrow, J (1994) . In Herd Health. Food Animal Production Medicine, 2nd ed., pp. 435–526 [Radostits, OM, editor]. London: Saunders.
4Davis, ME, Brown, DC, Baker, A, Bos, K, Dirain, MS, Halbrook, E, Johnson, ZB, Maxwell, C & Rehberger, T (2007) Effect of direct-fed microbial and antibiotic supplementation on gastrointestinal microflora, mucin histochemical characterization, and immune populations of weanling pigs. Livest Sci 108, 249–253.
5Bellamy, W, Takase, M, Yamauchi, K, Wakabayashi, H, Kawase, K & Tomita, M (1992) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121, 130–136.
6Kuwata, H, Yip, TT, Tomita, M & Hutchens, TW (1998) Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1429, 129–141.
7Kuwata, H, Yip, TT, Yamauchi, K, Teraguchi, S, Hayasawa, H & Tomita, M (1998) The survival of ingested lactoferrin in the gastrointestinal tract of adult mice. J Biochem 334, 321–323.
8Bellamy, W, Takase, M, Wakabayashi, H, Kawase, K & Tomita, M (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73, 472–479.
9Hwang, PM, Zhou, N, Shan, X, Arrowsmith, CH & Vogel, HJ (1998) Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37, 4288–4298.
10Tomita, M, Takase, M, Bellamy, W & Shimamura, S (1994) A review: the active peptide of lactoferrin. Acta Paediatr Jpn 36, 585–591.
11Groenink, J, Walgreen-Weterings, E, van't Hof, W, Veerman, ECI & Nieuw, AAV (1999) Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol Lett 179, 217–222.
12Wakabayashi, H, Matsumoto, H, Hashimoto, K, Teraguchi, S, Takase, M & Hayasawa, H (1999) N-acylated and d enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Chemother 43, 1267–1269.
13Yoo, YC, Watanabe, S, Watanabe, R, Hata, K, Shimazaki, K & Azuma, I (1997) Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88, 184–190.
14Bellamy, WR, Wakabayashi, H, Takase, M, Shimamura, S & Tomita, M (1993) Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Microbiol 75, 478–484.
15Wakabayashi, H, Hiratani, T, Uchida, K & Yamaguchi, H (1996) Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J Infect Chemother 1, 185–189.
16Valenti, P, Antonini, G, Siciliano, R, Rega, B, Superti, F, Marchetti, M, Ammendolia, MG & Seganti, L (2000) . In Lactoferrin: Structure, Function and Applications, pp. 181–186 [Shimazaki, K, Tsuda, H, Tomita, M, Kuwata, T and Perraudin, JP, editors]. New York: Elsevier Publishing.
17Andersen, JH, Osbakk, SA, Vorland, LH, Traavik, T & Gutteberg, TJ (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51, 141–149.
18Iigo, M, Kuhara, T, Ushida, Y, Sekine, K, Moore, MA & Tsuda, H (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17, 35–40.
19Brock, J (1995) Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 16, 417–419.
20Levay, PF & Viljoen, M (1995) Lactoferrin: a general review. Haematologica 80, 252–267.
21Marieke, IA, van der, K, Jasper, G, Kamran, N, Enno, CIV, Jan, GMB & Arie, VNA (2004) Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25, 177–183.
22van der Kraan, MI, Nazmi, K, van't Hof, W, Amerongen, AV, Veerman, EC & Bolscher, JG (2006) Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem Cell Biol 84, 358–362.
23Tang, ZR, (2007) .
24Montagne, L, Cavaney, FS, Hampson, DJ, Lallès, JP & Pluske, JR (2004) Effect of diet composition on postweaning colibacillosis in piglets. J Anim Sci 82, 2364–2374.
25Tang, ZR, Yin, YL, Nyachoti, CN, et al. (2005) Effect of dietary supplementation of chitosan and galacto-mannan-oligosaccharide on serum parameters and the insulin-like growth factor-I mRNA expression in early-weaned piglets. Domest Anim Endocrinol 28, 430–441.
26National Research Council (1998) Nutrient Requirements of Swine, 10th revised ed.Washington, DC: National Academic Press.
27Namkung, H, Gong, J, Yu, H & de Lange, CFM (2006) Effect of pharmacological intakes of zinc and copper on growth performance, circulating cytokines and gut microbiota of newly weaned piglets challenged with coliform lipopolysaccharides. Can J Anim Sci 86, 511–522.
28McManus, JFA (1946) Histological demonstration of mucin after periodic acid. Nature 158, 202–205.
29Kik, M, Huisman, JL & van der Poel, AFB (1990) Pathologic changes of the small intestinal mucosa of pigs after feeding Phaseolus vulgaris beans. Vet Pathol 27, 329–334.
30Callesen, J, Halas, D, Thorup, F, Bach, KKE, Kim, JC, Mullan, BP, Hampson, DJ, Wilson, RH & Pluske, JR (2007) The effects of weaning age, diet composition, and categorisation of creep feed intake by piglets on diarrhoea and performance after weaning. Livest Sci 108, 120–123.
31Arnold, RR, Cole, MF & McGhee, JR (1977) A bactericidal effect for human lactoferrin. Science 197, 263–265.
32Ellison, RT, Giehl, TJ & Laforce, FM (1988) Damage of the outer membrane of gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56, 2774–2781.
33Ulvatne, H, Haukland, HH, Olsvik, O & Vorland, LH (2001) Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett 492, 62–65.
34Mann, DM, Romm, E & Migliorini, M (1994) Delineation of glycosaminoglycan-binding site in human inflammatory response protein lactoferrin. J Biol Chem 269, 23661–23667.
35Elass-Rochard, E, Roseanu, A, Legrand, D, Trif, M, Salmon, V, Motas, C, Montreuil, J & Spik, G (1995) Lactoferrin–lipopolysaccharide interaction: involvement of the 28–34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. J Biochem 312, 839–845.
36Nikaido, H & Nakae, T (1979) The outer membrane of Gram-negative bacteria. Adv Microb Physiol 20, 163–250.
37Humphrey, BD, Huang, N & Klasing, KC (2002) Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J Nutr 132, 1214–1218.
38Swidsinski, A, Ladhoff, A, Pernthaler, A, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44–54.
39Gislason, J, Iyer, S, Hutchens, TW & Lonnerdal, B (1993) Lactoferrin receptors in piglet small intestine: lactoferrin binding properties, ontogeny, and regional distribution in the gastrointestinal tract. J Nutr Biochem 4, 528–533.
40Alessia, F, Paola, I & Alessandro, S (2007) Zinc, antioxidant systems and metallothionein in metal-mediated apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C 146, 443–459.
41Sies, H (1993) Strategies of antioxidant defense. Eur J Biochem 215, 213–219.
42Lindmark-Månsson, H & Åkesson, B (2000) Antioxidative factors in milk. Br J Nutr 84, Suppl. 1, S103–S110.
43Bihel, S & Birlouez-Aragon, I (1998) Inhibition of tryptophan oxidation in the presence of iron-vitamin C by bovine lactoferrin. Int Dairy J 8, 637–641.
44Bruininx, EM, van der Peet-Schwering, CM, Schrama, JW, Vereijken, PF, Vesseur, PC, Everts, H, den Hartog, LA & Beynen, AC (2001) Individually measured feed intake characteristics and growth performance of group-housed weanling pigs: effects of sex, initial body weight, and body weight distribution within groups. J Anim Sci 79, 301–308.
45Debbabi, H, Dubarry, M, Rautureau, M & Tomé, D (1998) Bovine lactoferrin induces both mucosal and systemic immune response in mice. J Dairy Res 65, 283–293.
46Prgomet, C, Prenner, ML, Schwarz, FJ & Pfaffl, MW (2007) Effect of lactoferrin on selected immune system parameters and the gastrointestinal morphology in growing calves. J Anim Physiol Anim Nutr 91, 109–119.
47Shu, Q, Qu, F & Gill, HS (2001) Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 33, 171–177.
48Trif, M, Guillen, C, Vaughan, DM, Elfer, TJM, Brewer, JM, Roseanu, A & Brock, JH (2001) Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp Biol Med 226, 559–564.
49Bavaye, S, Elass, E, Mazurier, J, Spik, G & Legrand, D (1999) Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37, 281–286.
50Adamik, B & Walszczyk, A (1996) Lactoferrin: its role in defence against infection and immunotropic properties (article in Polish). Postepy Hig Med Dosw 50, 33–41.
51Lonnerdal, B & Iyer, S (1995) Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15, 93–110.